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Bacterial chondroitinases (both ABC and AC types) release asymmetric and globular forms of AChE from chick skeletal muscle samples. Heparin- 
ases, however, including heparitinase I, fail to do so under different incubation conditions. These results do not support the direct implication 
of the heparin/heparan sulfate family of GAGS in the interaction of the different AChE molecular forms with the muscle ECM. GAGS of the 
chondroitin/dcrmatan sulfate group could however be involved, either directly or indirectly, in the attachment of the AChE collagen-like tail to 
the muscle basal lamina. 
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1. INTRODUCTION 
Experimental evidence has a.ccumulated uring re- 
cent years which supports the involvement of the 
glycosaminoglycan moiety of proteoglycans in the an- 
chorage of the asymmetric, collagen-tailed forms (A- 
forms) of acetylcholinesterase (AChE; EC 3.1.1.7) to 
the basal lamina, at the motor endplate, in vertebrate 
skeletal muscle [l-8]. Among glycosaminoglycans 
(GAGS), heparan sulfate has been singled out as the 
most likely candidate for this role in view of the proven 
affinity of the tailed AChE species for heparin [3-6,8], 
and of the reported ability of heparinases (but not chon- 
droitinases) to dissociate aggregative AChE-GAG com- 
plexes [2], and to release asymmetric AChE from elec- 
tric organ samples [S]. Our recent work has shown, 
however, that the affinity of heparin for the asymmetric 
AChE tail is not a selective phenomenon, being shared 
by a number of polyanions including sulfated GAGS, 
dextran sulfates, some acidic polyaminoacids and even 
polyvinylsulfates [9]. Since this finding puts additional 
weight on digestion experiments as a means to identify 
the molecule(s) responsible for the AChE-ECM in- 
teractions, we have carried out a detailed analysis of the 
effect of some GAG-lyases on chick skeletal muscle 
AChE. 
Abbreviutions: AC%, acctylcholincstcrasc; A-forms, asymmetric 
molecular forms; ECM, extracellular matrix; GAGs, glycosamino- 
glycans; GAG.lynscs, glycosaminoglycanJynscs; G.forms, globular 
moleculnr forms; TT buffer, 10 mM Tris-HCI, pH 7/0.50/o Triton 
X-100; TTSE buffer, ‘IT plus I M NnCI/S/mM EDTA 
Correspu&otce uddrex G. Ramircz, Centro de Uiologla Molecular 
(CSICJJAM). Universidad AutQnoma, 28049 Madrid, Spain. Fnx: 
(34) (I) 3Y 74 799. 
Two independent proccdurcs were used to properly evaluate the 
AChE activity released by GAG-lyases, especially A-forms which 
would not be soluble, even after release, due to the low salt concentra- 
tion in the incubation medium. In some experiments, the digested 
samples and the controls were quickly filtered through coarse glass 
fiber filters to remove most of the solid tissue (but not the released 
2. MATERIALS AND METHODS 
2.1, Enzymes 
Flavobacterium heparinurn heparinases 1, II and III (heparitinase 
I), and chondroitinase AC, and Proteus vulgaris chondroitinase ABC 
were purchased from Sigma. Enzymes from other sources (e.g. Miles 
heparitinase) were also occasionally used, with identical results. Since 
all these enzymes exhibit markedly different emperature and pH op- 
tima (which are in turn substrate-dependent) [lO,ll] special care was 
exercised to use them within their high activity range. Heparinases 
were initially tested in the following temperature ranges: I, 30-37’C; 
II, 30-42’6; and 111, 37-42’6 [l I], using chondroitinases always at 
37°C [lo]. As for pH, an interval of 7.0-7.4 was considered for all en- 
zymes, except that chondroitinase ABC was checked between 7.4 and 
8.0. No significant differences in activity were found within these 
ranges, perhaps due to the complexity of the substrate and to the high 
enzyme concentrations. Accordingly, and to facilitate experiments 
with enzyme mixtures, we adopted 37’C/pH 7.4 as the standard in- 
cubation conditions for all enzymes. 
2.2. Procedure 
Muscle samples from IO-day chick hindlimbs were first homogeniz- 
ed (4°C) in 10 mM Tris-HCI pH 7.0/0.5% Triton X-100 (TT buffer), 
containing 0.1 mg/ml bacitracin, to remove the bulk of the globular 
AChE forms. After centrifugation (140 OOOxg) the pellet was 
resuspended in 1 ml of 10 mM Tris-HCI pH 7.4/0.1010 Triton 
X-100/100 mM NaCVS mM calcium acetate, containing an an- 
tiprotease cock!nil (0.1 mg/ml bacitracin, 0.3 mg/ml benzamidine, 
0. I mg/ml leupeptin, 0.1 mg/ml trypsin inhibitor) and 5 U of the cor- 
responding GAG-lyase. Two control samples were always carried 
along with the experimental samples: the first was a background con- 
trol, homogenized in the same buffer plus antiproteases, but contain- 
ing no enzymes, to assess the spontaneous release of AChE during the 
incubation. The second was a measure of the A-forms available for 
extraction aud consisted of thesame sample as above but homogeniz- 
ed in TT buffer supplemented with 1 M NaCl and 5 mM EDTA 
(TTSE buffer) plus antiproteases. Incubations were carried out at 
37OC for 30 min. 
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Table I 
Release of molecular forms of AChE from cl=?- Ir’ 1 k ..!ndlimb muscle samples by different GAG-lyases 
Background Heparinases Chondroitinases TTSE control 
control (no (maximal release 
enzymes added) I II III ABC AC of A-forms) 
A-forms 3.2 * 0.8 2.9 i 0.6 3.1 * 0.5 2.8 + 0.8 5.9 f 0.9* 5.9 f 0.8' 19.2 c 1.6 
G-forms 4.0 * 0.5 3.7 f 0.4 4.0 f 0.5 3.2 t 0.6 6.6 r OS* 6.8 + 0.8’ 4.2 * 0.5 
All enzymes were used at a concentration of 5 U/ml, as explained in the text. Values (mean + SD) in the Table are expressed as % of the total 
AChE activity in the initial muscle sample (i.e. before the TT extraction: see section 2). The results for A-forms are based on 8 experiments (4 
of each type described in section 2), whereas, in the case of G-forms, only the results of 4 experiments (like the one depicted in Fig. I) have been 
taken it&account. 
*Differences with background controls are significant with PCO.001. 
asymmetric AChE aggregates, if any), and the filtrate layered on top 
of a S-20% sucrose gradient made up in TTSE buffer containing the 
usual sedimentation marker enzymes [g]. The rationale for this pro- 
cedure was to effect the total solubilization of the released AChE, 
while minimizing the exposure to high salt of the A-forms remaining 
attached to the particulate material (i.e. not released by the GAG- 
lyases). The differences between gradients containing samples and 
background controls would then be due to the specific action of the 
enzymes. The second protocol was a modification of the one used by 
lnestrosa and co-workers [5]; the digested samples and the controls 
were layered on top of I .5 ml of 45% sucrose, and centrifuged for 10 
min at 10 000 x g, Roth the supernatant and the heavy sucrose layer 
were immunoprecipitated with a monoclonal antibody specific for 
clrick asymmetric AChE to measure released A-forms. This antibody, 
prepared by immunization of mice with partially-purified chick mus- 
cle asymmetric AChE, and further selection of the specific clone, has 
been found to react with collagen-tailed AChE species, but not with 
G-forms, either buffer- or detergent-soluble, in both ELISA and im- 
munoprecipitation tests (Perez-Tur et al., unpublished). Four in- 
dependent experiments, including all enzymes, were carried out using 
each procedure. The procedure using gradient separation gave an 
estimate of both the asymmetric and globular AChE forms released 
by each enzyme. The method involving the sucrose cushion and im- 
munoprecipitation was only used to measure A-forms. 
3. RESULTS AND DISCUSSION 
We have analyzed the release of the molecular forms 
of AChE by incubation of chick skeletal muscle 
samples in the presence of specific GAG-lyases: 
heparinases I, II and III (heparitinase 1) and chon- 
droitinase ABC and AC. We have checked three dif- 
ferent heparinases taking into account the structural 
heterogeneity of the heparin/heparan sulfate family of 
GAGS: it is, for instance, a proven fact that heparan 
sulfates do often contain long heparin-like stretches 
[ 121. Besides, in our hands, heparin shows consistently 
more affinity for tailed AChE forms than heparan 
sulfate itself [8,9]. Actually, these enzymes how mixed 
specificities: ‘heparinase’ (heparinases I and II) acts 
equally well upon heparin and heparitin sulfaies C and 
D, wherecs heparitinase I (heparinase III) degra Ies only 
heparitin sulfates A and B [13]. In any case, Table I 
shows quite clearly that neither form of heparinase was 
ble to extract A-forms or G-forms above the 
background level. Chondroitinases (both ABC and AC, 
althou8h the quantitative results with each type are no 
directly comparable [lo]), however, released small but 
26 
consistently significant amounts of A- and G-forms. 
The enzyme concentrations used were much higher than 
usual [2,5], and we found that increasing them, or 
lengthening the incubation times only resulted in higher 
backgrounds. Anyway, chondroitinases released about 
one third of the A-forms that could be extracted with 
high salt (TTSE, maxima1 release control) from an iden- 
tical sample incubated (without enzymes) under the 
same conditions. High backgrounds, such as ours, were 
also reported by Brandan et al. [5]. The most critical 
aspect of these digestion experiments concerns the pro- 
cedures used to isolate the AChE released by the en- 
zymatic digestion by GAG-lyases. Our first procedure 
(see section 2) relies on a limited exposure of the 
digested material to high salt which allows a separation 
in sucrose gradients to the released AChE forms, so that 
both A- and G-forms can be accurately quantified, 
while preventing the massive solubilization of more A- 
forms in the presence of high salt (Fig. I). When first 
using the second protocol, taken from Brandan et al. 
151, we found that some 25% of A-forms entered the 
sucrose cushion (see section 2). To estimate all A- 
forms, we then had to immunoprecipitate he superna- 
tant and the heavy sucrose (not a suitable sample for 
gradients) with an antibody specific for A-forms. It is 
reassuring that both methods gave results (controls and 
A-forms) which were statistically similar, so that all the 
experiments have been analyzed together to obtain the 
mean values given in Table I. 
Our data suggest that GAGS of the chondroitin/der- 
matan sulfate family could be involved in the anchorage 
of asymmetric (and also, perhaps, globular) AChE to 
the muscle basal amina. The low yield of A-forms in 
our experiments could be tentatively explained by the 
existence, in the muscle basal amina, of a type of chon- 
droitin sulfate only partially sensitive to the bacterial 
chondroitinases used, Alternatively, the anchorage 
mechanisms could be heterogeneous, with chondroitin 
sulfates being the critical link in just a subpopulation of 
AChE molecules. To explore, within the latter 
hypothesis, the possibility of a joint involvement of 
both heparan and chondroitin sulfates in the attach- 
ment of extracellular muscle AChE we also measured 
the release of A-forms by a mixture of all heparinases 
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Fig. 1. Release of A- and G-forms of AChE by chondroitinase ABC 
from chick hindlimb muscle. Ten-day chick muscle samples, pre- 
extracted with TT buffer, were incubated with 5 U/ml of chon- 
droitinase, as described in section 2, along with control samples 
(background - Bckg - control, containing no enzyme, and maximal 
release control - valid only for A-forms -, containing high salt and 
EDTA). The digested samples were usually freed of the coarse par- 
ticulate material by filtration, and then layered on top of a S-2O”Io 
sucrose gradient, made up in TTSE buffer, together with sedimenta- 
tion markers [8]. These gradients were run, fractionated and assayed 
for ACM2 (nmol [‘“CJacetate released per min and fraction) and 
marker enzyme activities as described IB]. The arrows point the posi- 
tion of these marker enzymes, namely, from left to right, fl- 
galactosidase (16S), catalase (11.35), and alkaline phosphatase (6. IS). 
plus chondroitinase ABC, with the result of 6.3% A- 
forms released by the mixture vs 6.4% by chon- 
droitinase alone. Thus, the alleged role of (heparin-like) 
heparan sulfate GAGS [2,fi] is not supported by our 
results. 
The release of G-forms by chondroitinases above 
control level is a potentially interesting finding. On the 
one hand, it would seem to confirm previous reports by 
Jedrejczyk et al, [14], and Nicolet et al. [IS,161 describ- 
irrg the presence in muscle ECM, including the basal 
lamina, of typical G-forms, even perhaps involved in 
synaptic function. After all, as we have already shown, 
some G-forms do interact with GAGS at physiological 
ionic strength [8]. However, they could also derive from 
the degradation of A-forms during the incubation pro- 
cess. 
The lack af specificity of the heparin-AChE tail af- 
finity, shared as a matter of fact by many polyanions 
[9], and the results reported in this paper are at variance 
with the findings and hypotheses of Inestrosa and co- 
workers [S, 141 and make it necessary to re-evaluate the 
role of the different polyanions possibly present in the 
m.uscIe basal Iamina, including chondroitin sulfate-like 
GAGS, which incidentically were the first polyanions 
ever suggested to be involved in the well-known ag- 
gregation of A-forms at low ionic strength [ 1 J. 
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